Dr. Manley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Magnolia Drive
Tampa, FL 33612Phone+1 813-745-2226Fax+1 813-745-5939
Summary
- Dr. Brandon Manley is an urologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Temple University School of Medicine and has been in practice 9 years. He specializes in surgical oncology.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2015 - 2017
Washington University/B-JH/SLCH ConsortiumResidency, Urology, 2011 - 2015- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 2010 - 2011
Lewis Katz School of Medicine at Temple UniversityClass of 2010
Certifications & Licensure
FL State Medical License 2017 - 2025
NY State Medical License 2014 - 2018
MO State Medical License 2010 - 2015- American Board of Urology Urology
Awards, Honors, & Recognition
- Urology Care Research Scholar of the Year AUA, 2020
Clinical Trials
- Clinical Trial of Green Tea Catechins in Men on Active Surveillance Start of enrollment: 2020 Aug 21
- Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC Start of enrollment: 2020 Oct 26
Publications & Presentations
PubMed
- 17 citationsSurvival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.Nicholas H Chakiryan, L Robert Gore, Richard R Reich, Rodney L Dunn, Da David Jiang
JAMA Network Open. 2022-05-02 - 20 citationsReal-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma.Nicholas H. Chakiryan, Da David Jiang, Kyle A. Gillis, Elizabeth Green, Ali Hajiran
JAMA Network Open. 2021-05-03 - 4 citationsMulti-omics approach to identifying isoform variants as therapeutic targets in cancer patients.Timothy I Shaw, Bi Zhao, Yuxin Li, Hong Wang, Liang Wang
Frontiers in Oncology. 2022-01-01
Press Mentions
Spatial Patterns of Immune Cells Predict Patient Outcomes in Clear Cell Renal Cell CarcinomaApril 26th, 2023- Moffitt Researchers Discover Kidney Cancer-Specific Splicing Variant BiomarkersJuly 8th, 2022
Grant Support
- Bankhead-ColeyState of Florida2022–2026
Committees
- Board Member, Young Urologic Oncology 2022 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
